Nasdaq: RYTM
Rhythm Pharmaceuticals insiders
The officers, directors and 10% owners of Rhythm Pharmaceuticals, Inc. who hold the most stock, valued at the live RYTM price.
$116.80
RYTM today −$2.2M (−1.88%)
Market closed. Prices as of Nov 19, 4:04 PM ET
- Ranked insiders
- 6
- Their RYTM stock
- $51.3M
- Market value
- $8.23B
- Held by ranked insiders
- 0.62%
Insiders by value of RYTM holdings
SEC ownership page| # | Insider | Role | Shares | Value | Of company | Overall rank |
|---|---|---|---|---|---|---|
| 1 | David P. Meeker | President and CEO | 239,258 | $27.9M | 0.34% | 3486th |
| 2 | Hunter C. Smith | Chief Financial Officer | 114,024 | $13.3M | 0.16% | 7075th |
| 3 | Yann Mazabraud | EVP, Head of International | 55,655 | $6.5M | <0.1% | 12037th |
| 4 | Stuart A. Arbuckle | Director | 11,712 | $1.4M | <0.1% | 3304th |
| 5 | David W.J. McGirr | Director | 11,712 | $1.4M | <0.1% | 6266th |
| 6 | Camille L. Bedrosian | Director | 7,000 | $818K | <0.1% | 9587th |
Only insiders worth at least $5 million in listed stock are ranked. Holdings come from each insider's latest Form 3, 4 or 5 for Rhythm Pharmaceuticals; see each profile for the filing.